Production (Stage)
CASI Pharmaceuticals, Inc.
CASI
$1.33
-$0.51-27.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.70M | 16.09M | 20.81M | 12.73M | 19.66M |
| Total Receivables | 7.60M | 15.35M | 11.14M | 7.74M | 6.07M |
| Inventory | 4.15M | 5.25M | 12.93M | 14.61M | 15.42M |
| Prepaid Expenses | 2.71M | 2.89M | 2.27M | 2.11M | 2.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 27.16M | 39.58M | 47.15M | 37.20M | 43.15M |
|
|
|||||
| Total Current Assets | 27.16M | 39.58M | 47.15M | 37.20M | 43.15M |
| Net Property, Plant & Equipment | 10.92M | 11.36M | 12.40M | 10.25M | 10.85M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 233.00K | 238.00K | 1.12M | 1.36M | 1.62M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 590.00K | 587.00K | 702.00K | 692.00K | 702.00K |
| Total Assets | 40.82M | 53.67M | 63.62M | 51.27M | 58.01M |
|
|
|||||
| Total Accounts Payable | 1.20M | 2.72M | 1.76M | 792.00K | 583.00K |
| Total Accrued Expenses | 14.03M | 8.47M | 12.98M | 4.11M | 7.96M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.49M | 19.61M | -- | 429.00K | -- |
| Total Finance Division Other Current Liabilities | -- | 5.66M | -- | 4.25M | -- |
| Total Other Current Liabilities | -- | 5.66M | -- | 4.25M | -- |
| Total Current Liabilities | 33.71M | 36.45M | 14.74M | 9.58M | 8.54M |
|
|
|||||
| Total Current Liabilities | 33.71M | 36.45M | 14.74M | 9.58M | 8.54M |
| Long-Term Debt | -- | -- | 19.12M | 18.47M | 18.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 2.54M | -- | 1.38M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.18M | 12.84M | 15.91M | 12.82M | 15.41M |
| Total Liabilities | 48.89M | 51.82M | 49.77M | 42.25M | 42.54M |
|
|
|||||
| Common Stock & APIC | 714.59M | 713.30M | 712.60M | 699.37M | 696.52M |
| Retained Earnings | -710.83M | -700.08M | -685.71M | -677.31M | -670.35M |
| Treasury Stock & Other | -11.83M | -11.38M | -13.05M | -13.04M | -10.71M |
| Total Common Equity | -8.07M | 1.85M | 13.85M | 9.02M | 15.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.07M | 1.85M | 13.85M | 9.02M | 15.47M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.07M | 1.85M | 13.85M | 9.02M | 15.47M |
|
|
|||||